BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32813746)

  • 1. Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression.
    Romero-Medina MC; Venuti A; Melita G; Robitaille A; Ceraolo MG; Pacini L; Sirand C; Viarisio D; Taverniti V; Gupta P; Scalise M; Indiveri C; Accardi R; Tommasino M
    PLoS Pathog; 2020 Aug; 16(8):e1008792. PubMed ID: 32813746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.
    Pacini L; Ceraolo MG; Venuti A; Melita G; Hasan UA; Accardi R; Tommasino M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
    Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
    J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
    Pacini L; Savini C; Ghittoni R; Saidj D; Lamartine J; Hasan UA; Accardi R; Tommasino M
    J Virol; 2015 Nov; 89(22):11396-405. PubMed ID: 26339055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.
    Dong W; Kloz U; Accardi R; Caldeira S; Tong WM; Wang ZQ; Jansen L; Dürst M; Sylla BS; Gissmann L; Tommasino M
    J Virol; 2005 Dec; 79(23):14899-908. PubMed ID: 16282489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.
    Accardi R; Dong W; Smet A; Cui R; Hautefeuille A; Gabet AS; Sylla BS; Gissmann L; Hainaut P; Tommasino M
    EMBO Rep; 2006 Mar; 7(3):334-40. PubMed ID: 16397624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.
    Cornet I; Bouvard V; Campo MS; Thomas M; Banks L; Gissmann L; Lamartine J; Sylla BS; Accardi R; Tommasino M
    J Virol; 2012 Feb; 86(4):2366-70. PubMed ID: 22171257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.
    Viarisio D; Mueller-Decker K; Kloz U; Aengeneyndt B; Kopp-Schneider A; Gröne HJ; Gheit T; Flechtenmacher C; Gissmann L; Tommasino M
    PLoS Pathog; 2011 Jul; 7(7):e1002125. PubMed ID: 21779166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.
    McKenna DJ; McDade SS; Patel D; McCance DJ
    J Virol; 2010 Oct; 84(20):10644-52. PubMed ID: 20702634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints.
    Dong W; Arpin C; Accardi R; Gissmann L; Sylla BS; Marvel J; Tommasino M
    Oncogene; 2008 May; 27(20):2923-8. PubMed ID: 18026133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown.
    Diaz D; Santander MA; Chavez JA
    Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins.
    Minoni L; Romero-Medina MC; Venuti A; Sirand C; Robitaille A; Altamura G; Le Calvez-Kelm F; Viarisio D; Zanier K; Müller M; Accardi R; Tommasino M
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.
    Dogra S; Bandi S; Viswanathan P; Gupta S
    Cancer Lett; 2015 Jan; 356(2 Pt B):953-61. PubMed ID: 25444910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout.
    Abboodi F; Buckhaults P; Altomare D; Liu C; Hosseinipour M; Banister CE; Creek KE; Pirisi L
    Virology; 2021 Feb; 554():9-16. PubMed ID: 33321328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles.
    Azzimonti B; Dell'oste V; Borgogna C; Mondini M; Gugliesi F; De Andrea M; Chiorino G; Scatolini M; Ghimenti C; Landolfo S; Gariglio M
    Virology; 2009 Jun; 388(2):260-9. PubMed ID: 19398117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
    Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
    Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.